Your Health, We Care
Cancer cachexia patients with unresectable advanced/recurrent non-small cell lung cancer, gastric cancer, pancreatic cancer, colorectal cancer, nutritional treatment and other poor effects are also suitable for patients who lose more than 5% of their weight within 6 months of treatment and have anorexia accompanied by other discomfort.
fromJP,2023.02
Anamorelin is the first cachexia treatment drug launched in Japan in 2021, which···【more】
Release date：2024-08-20Recommended：148
Launched in Japan in 2021, anamoline is the world's first drug specifically ···【more】
Release date：2024-08-20Recommended：134
Anamorelin is the world's first drug specifically for the treatment of cache···【more】
Release date：2024-08-20Recommended：170
Anamorelin represents a pioneering intervention for cancer-associated cachexia, ···【more】
Release date：2024-08-05Recommended：112
Anamorelin is a pharmaceutical innovation crafted and manufactured by Ono, Japan···【more】
Release date：2024-08-05Recommended：101
Adlumiz exhibits a diverse array of applications within the realm of medicine, f···【more】
Release date：2024-08-05Recommended：104
